IL17B and neoplasm: It has been found that activation of IL-17B/RB on tumor cells can subsequently phosphorylate and activate ERK1/2, enhance the production of a series of chemokines, such as C-C motif chemokine ligands, and ultimately promote the recruitment of neutrophils, lymphocytes, and endothelial cells.